RNA logo

RNA
Avidity Biosciences Inc

1,631
Mkt Cap
$10.99B
Volume
3.22M
52W High
$73.06
52W Low
$21.51
PE Ratio
-17.49
RNA Fundamentals
Price
$72.79
Prev Close
$72.93
Open
$72.95
50D MA
$72.05
Beta
1.27
Avg. Volume
1.7M
EPS (Annual)
-$2.89
P/B
5.67
Rev/Employee
$27,869.56
Loading...
Loading...
News
all
press releases
Novartis Beats on Q4 Earnings, Entresto Generics Pressure Sales
NVS tops Q4 EPS estimates as margins expand, but revenues miss the mark amid U.S. generics hitting Entresto and Promacta, reshaping its growth mix.
Zacks·5h ago
News Placeholder
More News
News Placeholder
Atle Fund Management AB Makes New Investment in Avidity Biosciences, Inc. $RNA
Atle Fund Management AB acquired a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·3d ago
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBHC, RNA, NEW, and TWO
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBHC, RNA, NEW, and TWO $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBHC, RNA...
PR Newswire·5d ago
News Placeholder
Mutual of America Capital Management LLC Trims Stake in Avidity Biosciences, Inc. $RNA
Mutual of America Capital Management LLC lessened its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 15.2% during the third quarter, according to its most recent disclosure with...
MarketBeat·6d ago
News Placeholder
Avidity Biosciences (NASDAQ:RNA) Reaches New 12-Month High - Here's What Happened
Avidity Biosciences (NASDAQ:RNA) Hits New 52-Week High - Still a Buy...
MarketBeat·13d ago
News Placeholder
Immunocore (IMCR) Soars 5.9%: Is Further Upside Left in the Stock?
Immunocore (IMCR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks·13d ago
News Placeholder
Avidity Biosciences (NASDAQ:RNA) Hits New 1-Year High - Here's What Happened
Avidity Biosciences (NASDAQ:RNA) Reaches New 12-Month High - What's Next...
MarketBeat·20d ago
News Placeholder
Avidity Biosciences (NASDAQ:RNA) Insider Sells 2,373 Shares
Avidity Biosciences, Inc. (NASDAQ:RNA - Get Free Report) insider Steven George Hughes sold 2,373 shares of the firm's stock in a transaction that occurred on Wednesday, January 7th. The stock was...
MarketBeat·26d ago
News Placeholder
Charles Calderaro III Sells 3,727 Shares of Avidity Biosciences (NASDAQ:RNA) Stock
Avidity Biosciences, Inc. (NASDAQ:RNA - Get Free Report) insider Charles Calderaro III sold 3,727 shares of the stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at...
MarketBeat·26d ago
News Placeholder
Insider Selling: Avidity Biosciences (NASDAQ:RNA) CEO Sells 8,576 Shares of Stock
Avidity Biosciences, Inc. (NASDAQ:RNA - Get Free Report) CEO Sarah Boyce sold 8,576 shares of the firm's stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price...
MarketBeat·26d ago
<
1
2
...
>

Latest RNA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.